AIM:TLY

Stock Analysis Report

Executive Summary

Totally plc, through its subsidiaries, provides out-of-hospital healthcare services in the United Kingdom and Ireland.

Snowflake

Fundamentals

Adequate balance sheet and fair value.

Share Price & News

How has Totally's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

14.9%

TLY

5.8%

GB Healthcare

1.9%

GB Market


1 Year Return

-36.2%

TLY

-7.2%

GB Healthcare

2.4%

GB Market

Return vs Industry: TLY underperformed the UK Healthcare industry which returned -7.2% over the past year.

Return vs Market: TLY underperformed the UK Market which returned 2.4% over the past year.


Shareholder returns

TLYIndustryMarket
7 Day14.9%5.8%1.9%
30 Day29.3%-4.7%-1.1%
90 Day18.5%8.2%-1.8%
1 Year-36.2%-36.2%-5.7%-7.2%7.4%2.4%
3 Year-79.4%-79.4%-13.6%-17.5%18.2%3.7%
5 Year-67.6%-67.6%98.6%88.3%35.7%6.1%

Price Volatility Vs. Market

How volatile is Totally's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Totally undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Undervalued: TLY (£0.12) is trading below our estimate of fair value (£0.7)

Significantly Undervalued: TLY is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: TLY is unprofitable, so we can't compare its PE Ratio to the Healthcare industry average.

PE vs Market: TLY is unprofitable, so we can't compare its PE Ratio to the UK market.


Price to Earnings Growth Ratio

Low PEG Ratio: Insufficient data to calculate TLY's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: TLY is good value based on its PB Ratio (0.3x) compared to the GB Healthcare industry average (1.2x).


Next Steps

Future Growth

How is Totally forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?

54.2%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: TLY is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: TLY is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: TLY is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: TLY's revenue (20.2% per year) is forecast to grow faster than the UK market (3.9% per year).

High Growth Revenue: TLY's revenue (20.2% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

High Future ROE: TLY's Return on Equity is forecast to be low in 3 years time (10.8%).


Next Steps

Past Performance

How has Totally performed over the past 5 years?

9.5%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Earnings Trend: TLY is unprofitable, but has reduced losses over the past 5 years at a rate of 9.5% per year.

Accelerating Growth: Unable to compare TLY's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: TLY is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (8.3%).


Return on Equity

High ROE: TLY has a negative Return on Equity (-5.8%), as it is currently unprofitable.


Return on Assets

ROA vs Industry: TLY is currently unprofitable, so its Return on Assets is negative.


Return on Capital Employed

ROCE Improving: TLY is currently unprofitable, so its Return on Capital Employed is negative.


Next Steps

Financial Health

How is Totally's financial position?


Financial Position Analysis

Short Term Liabilities: TLY's short term assets (£16.2M) do not cover its short term liabilities (£19.1M)

Long Term Liabilities: TLY's short term assets (16.2M) exceeds its long term liabilities (785.0K)


Debt to Equity History and Analysis

Debt Level: TLY is debt free.

Reducing Debt: TLY had no debt 5 years ago.


Balance Sheet

Inventory Level: TLY has a low level of unsold assets or inventory.

Debt Coverage by Assets: Insufficient data to determine if TLY's debt is covered by short term assets.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: TLY has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if TLY has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Next Steps

Dividend

What is Totally's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%2.0%markettop25%5.4%industryaverage1.5%forecastin3Yearsn/a

Current dividend yield vs market & industry


Stability and Growth of Payments

Notable Dividend: Unable to evaluate TLY's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate TLY's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.

Stable Dividend: Insufficient data to determine if TLY's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if TLY's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of TLY's dividend in 3 years as they are not forecast to pay a notable one for the UK market.


Next Steps

Management

What is the CEO of Totally's salary, the management and board of directors tenure and is there insider trading?

2.0yrs

Average management tenure


CEO

Wendy Lawrence (57yo)

6.4yrs

Tenure

UK£163,000

Compensation

Mrs. Wendy Jayne Lawrence serves as Chief Executive and Managing Director at Totally Health Limited. Mrs. Lawrence has been the Chief Executive Officer of Totally plc since May 2013 and served as its Actin ...


CEO Compensation Analysis

Compensation vs. Market: Wendy's total compensation ($USD209.69K) is about average for companies of similar size in the UK market ($USD320.04K).

Compensation vs Earnings: Wendy's compensation has been consistent with company performance over the past year.


Management Age and Tenure

2.0yrs

Average Tenure

53.5yo

Average Age

Experienced Management: TLY's management team is considered experienced (2 years average tenure).


Board Age and Tenure

3.8yrs

Average Tenure

64yo

Average Age

Experienced Board: TLY's board of directors are considered experienced (3.8 years average tenure).


Insider Trading

Insider Buying: TLY insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

BuyUK£704 Oct 19
Robert Holt
EntityIndividual
Role
Chairman of the Board
Non-Executive Chairman
Shares80
Max PriceUK£0.091
BuyUK£1,89310 Sep 19
Wendy Lawrence
EntityIndividual
Role
Chief Executive Officer
CEO & Executive Director
Shares20,000
Max PriceUK£0.095
BuyUK£8,05110 Sep 19
Michael Rogers
EntityIndividual
Role
Member of the Board of Directors
Non-Executive Director
Shares84,000
Max PriceUK£0.096
BuyUK£10,93324 Jun 19
Robert Holt
EntityIndividual
Role
Chairman of the Board
Non-Executive Chairman
Shares111,000
Max PriceUK£0.099
BuyUK£4,96921 Jun 19
Gloria Cooke
EntityIndividual
Role
Member of the Board of Directors
Clinical Quality Director & Director
Shares50,500
Max PriceUK£0.098
SellUK£358,62118 Feb 19
Michael Harrison
EntityIndividual
Shares2,868,977
Max PriceUK£0.13
SellUK£358,62118 Feb 19
John Harrison
EntityIndividual
Shares2,868,977
Max PriceUK£0.13

Ownership Breakdown


Management Team

  • Wendy Lawrence (57yo)

    CEO & Executive Director

    • Tenure: 6.4yrs
    • Compensation: UK£163.00k
  • Wayne Llewellyn (56yo)

    CEO & Clinical Director of Premier Physical Healthcare

    • Tenure: 0yrs
  • Richard Benson (51yo)

    Chief Executive Officer of About Health

    • Tenure: 3.3yrs
  • Gloria Cooke (66yo)

    Clinical Quality Director & Director

    • Tenure: 1.8yrs
    • Compensation: UK£112.00k
  • Lisa Barter-Ng (48yo)

    Finance Director & Director

    • Tenure: 2yrs
    • Compensation: UK£117.00k
  • Andy Gregory

    Managing Director of Vocare

    • Tenure: 0yrs
  • John Charlton

    Group Company Secretary

    • Tenure: 0yrs
  • Michael Steel (49yo)

    Executive Director

    • Tenure: 0.3yrs
  • Emma-Jayne Perez-Chies

    Director of Human Resources & Organisational Development

    • Tenure: 0yrs

Board Members

  • Tony Bourne (65yo)

    Non-Executive Director

    • Tenure: 4yrs
    • Compensation: UK£25.00k
  • Bob Holt (64yo)

    Non-Executive Chairman

    • Tenure: 4.1yrs
  • Mike Rogers (77yo)

    Non-Executive Director

    • Tenure: 3.8yrs
    • Compensation: UK£25.00k
  • Wendy Lawrence (57yo)

    CEO & Executive Director

    • Tenure: 6.4yrs
    • Compensation: UK£163.00k
  • Gloria Cooke (66yo)

    Clinical Quality Director & Director

    • Tenure: 1.8yrs
    • Compensation: UK£112.00k
  • Lisa Barter-Ng (48yo)

    Finance Director & Director

    • Tenure: 2yrs
    • Compensation: UK£117.00k
  • Michael Steel (49yo)

    Executive Director

    • Tenure: 0.3yrs

Company Information

Totally plc's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Totally plc
  • Ticker: TLY
  • Exchange: AIM
  • Founded: 1999
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: UK£22.272m
  • Shares outstanding: 182.19m
  • Website: https://www.totallyplc.com

Number of Employees


Location

  • Totally plc
  • Cardinal Square
  • First Floor West
  • Derby
  • Derbyshire
  • DE1 3 QT
  • United Kingdom

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
TLYAIM (London Stock Exchange AIM Market)YesOrdinary SharesGBGBPJan 2000
UKXADB (Deutsche Boerse AG)YesOrdinary SharesDEEURJan 2000

Biography

Totally plc, through its subsidiaries, provides out-of-hospital healthcare services in the United Kingdom and Ireland. The company offers a range of treatments and advice for musculoskeletal injuries and c ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/10/17 20:33
End of Day Share Price2019/10/17 00:00
Earnings2019/03/31
Annual Earnings2019/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.